CV Sciences Statistics
Total Valuation
CV Sciences has a market cap or net worth of 6.01 million. The enterprise value is 7.20 million.
| Market Cap | 6.01M |
| Enterprise Value | 7.20M |
Important Dates
The last earnings date was Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CV Sciences has 197.33 million shares outstanding. The number of shares has increased by 2.24% in one year.
| Current Share Class | 197.33M |
| Shares Outstanding | 197.33M |
| Shares Change (YoY) | +2.24% |
| Shares Change (QoQ) | +1.44% |
| Owned by Insiders (%) | 8.05% |
| Owned by Institutions (%) | n/a |
| Float | 181.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.45 |
| PB Ratio | 4.02 |
| P/TBV Ratio | 14.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.82 |
| EV / Sales | 0.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -24.23 |
Financial Position
The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.99.
| Current Ratio | 0.96 |
| Quick Ratio | 0.14 |
| Debt / Equity | 0.99 |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.02 |
| Interest Coverage | -1.74 |
Financial Efficiency
Return on equity (ROE) is -88.02% and return on invested capital (ROIC) is -27.25%.
| Return on Equity (ROE) | -88.02% |
| Return on Assets (ROA) | -6.90% |
| Return on Invested Capital (ROIC) | -27.25% |
| Return on Capital Employed (ROCE) | -51.82% |
| Weighted Average Cost of Capital (WACC) | 10.21% |
| Revenue Per Employee | 311,116 |
| Profits Per Employee | -34,698 |
| Employee Count | 44 |
| Asset Turnover | 1.85 |
| Inventory Turnover | 1.63 |
Taxes
In the past 12 months, CV Sciences has paid 2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.23% in the last 52 weeks. The beta is 0.45, so CV Sciences's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +17.23% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 47.35 |
| Average Volume (20 Days) | 513,586 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CV Sciences had revenue of 13.38 million and -1.49 million in losses. Loss per share was -0.01.
| Revenue | 13.38M |
| Gross Profit | 6.66M |
| Operating Income | -799,000 |
| Pretax Income | -1.49M |
| Net Income | -1.49M |
| EBITDA | -666,000 |
| EBIT | -799,000 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 309,000 in cash and 1.49 million in debt, with a net cash position of -1.18 million or -0.01 per share.
| Cash & Cash Equivalents | 309,000 |
| Total Debt | 1.49M |
| Net Cash | -1.18M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 1.50M |
| Book Value Per Share | 0.01 |
| Working Capital | -185,000 |
Cash Flow
In the last 12 months, operating cash flow was -225,000 and capital expenditures -72,000, giving a free cash flow of -297,000.
| Operating Cash Flow | -225,000 |
| Capital Expenditures | -72,000 |
| Depreciation & Amortization | 133,000 |
| Net Borrowing | -188,000 |
| Free Cash Flow | -297,000 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 49.75%, with operating and profit margins of -5.97% and -11.15%.
| Gross Margin | 49.75% |
| Operating Margin | -5.97% |
| Pretax Margin | -11.14% |
| Profit Margin | -11.15% |
| EBITDA Margin | -4.98% |
| EBIT Margin | -5.97% |
| FCF Margin | n/a |
Dividends & Yields
CV Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.24% |
| Shareholder Yield | -2.24% |
| Earnings Yield | -24.81% |
| FCF Yield | -4.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |